iTeos Therapeutics, Inc.
ITOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$134,414 | -$112,642 | $96,652 | $214,521 |
| Dep. & Amort. | $1,238 | $898 | $803 | $603 |
| Deferred Tax | $0 | -$3,036 | $0 | $0 |
| Stock-Based Comp. | $29,941 | $27,021 | $21,561 | $13,794 |
| Change in WC | $18,647 | -$8,799 | -$228,491 | $284,210 |
| Other Non-Cash | -$13,593 | -$7,198 | -$1,718 | $12 |
| Operating Cash Flow | -$98,181 | -$103,756 | -$111,193 | $513,140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,633 | -$2,966 | -$938 | -$1,181 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$520,801 | -$290,541 | -$445,004 | $0 |
| Inv. Sales/Matur. | $391,308 | $366,264 | $0 | $0 |
| Other Inv. Act. | -$25 | -$99 | -$120 | -$61 |
| Investing Cash Flow | -$131,151 | $72,658 | -$446,062 | -$1,242 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $119,994 | $1,113 | $925 | $2,943 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,247 | $0 | $1,059 | $716 |
| Financing Cash Flow | $122,241 | $1,113 | $1,984 | $3,659 |
| Forex Effect | -$1,930 | -$3,602 | -$8,526 | -$3,176 |
| Net Chg. in Cash | -$109,021 | -$33,587 | -$563,797 | $512,381 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251,451 | $285,038 | $848,835 | $336,454 |
| End Cash | $142,430 | $251,451 | $285,038 | $848,835 |
| Free Cash Flow | -$99,814 | -$106,722 | -$112,131 | $511,959 |